Inventor · disambiguated record
Nian E. Zhou
Also filed as: ZHOU NIAN · ZHOU NIAN E · ZHOU NIAN EN
16 granted patents·9 pending applications·160 citations·filing 1996–2022
92Inventor score
Files withTEXAS A & M UNIV SYS7CA NAT RESEARCH COUNCIL3DECODE GENETICS EHF3UNIV ILLINOIS3NAEJA PHARMACEUTICAL INC2
Top patents by PatentIndex Score
25 records- 0180US7598397B2Sulfonamide peri-substituted bicyclics for occlusive artery diseaseDECODE GENETICS EHF·Filed 2005·Granted Oct 6, 2009·4 cites·10 claims
- 0277US7701092B1Connector module with embedded power-over-ethernet voltage isolation and methodAVAYA INC·Filed 2003·Granted Apr 20, 2010·28 cites·25 claims
- 0377US6569842B2Method of preparing and use of prodrugs of betulinic acid derivativesUNIV ILLINOIS·Filed 2001·Granted May 27, 2003·8 cites·7 claims
- 0475US5959123A3,4-Disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulatorsSYNPHAR LAB INC·Filed 1997·Granted Sep 28, 1999·40 cites·29 claims
- 0574US6635621B1Cysteine protease inhibitorsNAEJA PHARMACEUTICAL INC·Filed 2000·Granted Oct 21, 2003·10 cites·11 claims
- 0673US5916887A4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulatorsCA NAT RESEARCH COUNCIL·Filed 1997·Granted Jun 29, 1999·31 cites·14 claims
- 0771US11083717B2Compositions and methods for drug sensitization of parasitesTEXAS A & M UNIV SYS·Filed 2019·Granted Aug 10, 2021·0 cites·20 claims
- 0869US10226455B2Compositions and methods for drug sensitization of parasitesSACCHETTINI JAMES C·Filed 2016·Granted Mar 12, 2019·1 cites·18 claims
- 0963US7091195B2Method of preparing and use of prodrugs of betulinic acid derivativesUNIV ILLINOIS·Filed 2003·Granted Aug 15, 2006·1 cites·6 claims
- 1060US2009291948A1Sulfonamide peri-substituted bicyclics for occlusive artery diseaseDECODE GENETICS EHF·Filed 2009·Application pending·0 cites
- 1160US2025074907A1Inhibitors of sars-cov-2TEXAS A & M UNIV SYS·Filed 2022·Application pending·0 cites
- 1259US2015017673A1Compositions and methods for drug-sensitization or inhibition of a cancer cellSACCHETTINI JAMES·Filed 2013·Application pending·0 cites
- 1358US2019142817A1Compositions and methods for drug sensitization of parasitesTEXAS A & M UNIV SYS·Filed 2019·Application pending·0 cites
- 1457US2025084091A1Inhibitors of sars-cov-2TEXAS A & M UNIV SYS·Filed 2022·Application pending·0 cites
- 1556US5905076A6-substituted amino-4-oxa-1-azabicyclo 3,2,0! heptan-7-one derivatives as cysteine protease inhibitorsCA NAT RESEARCH COUNCIL·Filed 1997·Granted May 18, 1999·17 cites·11 claims
- 1655US6034077A4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulatorsCA NAT RESEARCH COUNCIL·Filed 1999·Granted Mar 7, 2000·11 cites·15 claims
- 1755US2007072835A1Method of preparing and use of prodrugs of betulinic acid derivativesUNIV ILLINOIS·Filed 2006·Application pending·0 cites
- 1854US10543200B2Compositions and methods for drug sensitization of parasitesTEXAS A & M UNIV SYS·Filed 2016·Granted Jan 28, 2020·0 cites·8 claims
- 1950US2019314381A1Compositions and methods for inhibition of mycobacteriaTEXAS A & M UNIV SYS·Filed 2019·Application pending·0 cites
- 2049US10300071B2Compositions and methods for inhibition of mycobacteriaTEXAS A & M UNIV SYS·Filed 2016·Granted May 28, 2019·0 cites·18 claims
- 2139US7714017B2Carboxylic acid peri-substituted bicyclics for occlusive artery diseaseDECODE GENETICS EHF·Filed 2005·Granted May 11, 2010·0 cites·13 claims
- 2237US5925633A3-Substituted-4-oxa-1-azabicyclo 3,2,0!heptan-7-one as cysteine protease inhibitorsSYNPHAR LABORATIES INC·Filed 1996·Granted Jul 20, 1999·7 cites·9 claims
- 2337US2004024000A1Dihydropyrimidine derivatives as cysteine protease inhibitorsFiled 2001·Application pending·0 cites
- 2436US2004164619A1Connector module with embedded Power-Over-Ethernet functionalityFiled 2003·Application pending·0 cites
- 2535US6232305B1Substituted amino bicyclic-β-lactam penam and cepham derivatives as cysteine protease inhibitorsNAEJA PHARMACEUTICAL INC·Filed 1998·Granted May 15, 2001·2 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →